---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016719"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:49:05.374911+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $67,860 convertible note with 35% conversion discount to 1800 Diagonal Lending

## Summary
- Principal $67,860 for net $58,000; matures Apr 16, 2026; 15% one-time interest.
- Conversion at 65% of lowest trading price in prior 10 days (35% discount); dilution risk.
- Payments: $39,019.50 on Dec 15, 2025; then $9,754.88 on Jan 15, Feb 15, Mar 15, Apr 15, 2026.
- Default triggers immediate acceleration; includes failure to pay, maintain OTC listing, or SEC reporting.
- Proceeds for general working capital; note issued under Regulation D, not registered.

## SEC filing metadata
- accession: 0001641172-25-016719
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000164117225016719/0001641172-25-016719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000164117225016719/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016719
- JSON: https://secwatch.observer/filing/0001641172-25-016719.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016719.txt

## Key facts
- Debt Financings
  Propanc Biopharma, Inc. incurred convertible notes of $67,860.00 with an investor at one-time interest charge of fifteen percent (15%) maturing April 16, 2026.
  - Instrument: convertible notes
  - Principal: $67,860.00
  - Counterparty: an investor
  - Rate: one-time interest charge of fifteen percent (15%)
  - Maturity: April 16, 2026
  - Event: incurrence
  source text: with an investor (the “Investor”) pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $67,860.00 (the “Note”), for a purchase price of $58,000. The Company intends to use the net proceeds therefrom for general working capital purposes. The maturity date of the Note is April
  evidence_url: https://www.sec.gov/Archives/edgar/data/1517681/000164117225016719/0001641172-25-016719-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.